Kuros Biosciences AG banner

Kuros Biosciences AG
OTC:CSBTF

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
OTC:CSBTF
Watchlist
Price: 24.75 USD Market Closed
Market Cap: $913.4m

Wall St Price Targets

CSBTF Price Targets Summary
Kuros Biosciences AG

Wall Street analysts forecast CSBTF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSBTF is 50.76 USD with a low forecast of 50.26 USD and a high forecast of 52.25 USD.

Lowest Forecast
Price Target
50.26 USD
103% Upside
Average Forecast
Price Target
50.76 USD
105% Upside
Highest Forecast
Price Target
52.25 USD
111% Upside
Kuros Biosciences AG Competitors:
Price Targets
NNOX
Nano-X Imaging Ltd
263% Upside
MDLZ
Mondelez International Inc
11% Upside
SMCP
SMCP SA
81% Upside
INO
Inovio Pharmaceuticals Inc
505% Upside
AMSF
Amerisafe Inc
26% Upside

Revenue
Forecast

38% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
38% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 38%. The projected CAGR for the next 3 years is 39%.

Operating Income
Forecast

N/A
Past Growth
95% / Year
Estimated Growth
Estimates Accuracy
34%
Average Beat
N/A
Past Growth
95% / Year
Estimated Growth
Estimates Accuracy
34%
Average Beat

The compound annual growth rate for Operating Income over the next 3 years is 95%.

Net Income
Forecast

N/A
Past Growth
163% / Year
Estimated Growth
Estimates Accuracy
-99%
Average Miss
N/A
Past Growth
163% / Year
Estimated Growth
Estimates Accuracy
-99%
Average Miss

The compound annual growth rate for Net Income over the next 3 years is 163%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CSBTF's stock price target?
Price Target
50.76 USD

According to Wall Street analysts, the average 1-year price target for CSBTF is 50.76 USD with a low forecast of 50.26 USD and a high forecast of 52.25 USD.

What is the Revenue forecast for Kuros Biosciences AG?
Projected CAGR
39%

Over the last 14 years, the compound annual growth rate for Revenue has been 38%. The projected CAGR for the next 3 years is 39%.

What is the Operating Income forecast for Kuros Biosciences AG?
Projected CAGR
95%

The compound annual growth rate for Operating Income over the next 3 years is 95%.

What is the Net Income forecast for Kuros Biosciences AG?
Projected CAGR
163%

The compound annual growth rate for Net Income over the next 3 years is 163%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett